Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Antibodies (Basel, Switzerland)
|
October 24, 2023
Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody-Drug Conjugate
Yue Huang, Jiaqi Yuan, Ruipeng Mu, et al.
Scientific Reports
|
November 19, 2021
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease
Sergei Pechenov, Jefferson Revell, Sarah Will, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
Mark D Pegram, Erika P Hamilton, Antoinette R Tan, et al.
Analytical Chemistry
|
October 21, 2022
Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination
Ruipeng Mu, Yue Huang, Jerome Bouquet, et al.
Bioanalysis
|
February 20, 2025
Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum
Weiwen Sun, Si Mou, Catherine Huntington, et al.
Analytical Chemistry
|
May 28, 2020
Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody-Drug Conjugate
Yue Huang, Christopher J Del Nagro, Kemal Balic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
Johann S de Bono, Mark T Fleming, Judy S Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 28, 2021
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
Christian T Ruff, Michael J Koren, Joseph Grimsby, et al.
Science Translational Medicine
|
April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
John E Le Lay, Qun Du, Minal B Mehta, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Antibodies (Basel, Switzerland)
|
October 24, 2023
Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody-Drug Conjugate
Yue Huang, Jiaqi Yuan, Ruipeng Mu, et al.
Scientific Reports
|
November 19, 2021
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease
Sergei Pechenov, Jefferson Revell, Sarah Will, et al.
Molecular Cancer Therapeutics
|
May 28, 2021
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer
Mark D Pegram, Erika P Hamilton, Antoinette R Tan, et al.
Analytical Chemistry
|
October 21, 2022
Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination
Ruipeng Mu, Yue Huang, Jerome Bouquet, et al.
Bioanalysis
|
February 20, 2025
Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum
Weiwen Sun, Si Mou, Catherine Huntington, et al.
Analytical Chemistry
|
May 28, 2020
Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody-Drug Conjugate
Yue Huang, Christopher J Del Nagro, Kemal Balic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 2, 2021
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide
Johann S de Bono, Mark T Fleming, Judy S Wang, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 27, 2024
Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression
Christina Vasalou, Theresa A Proia, Laura Kazlauskas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 28, 2021
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
Christian T Ruff, Michael J Koren, Joseph Grimsby, et al.
Science Translational Medicine
|
April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial
John E Le Lay, Qun Du, Minal B Mehta, et al.
Page
of 5